Skip to main content
. 2025 Dec 14;17(24):3986. doi: 10.3390/cancers17243986
AC adjuvant chemotherapy
BC bladder cancer
LVI lymphovascular invasion
MIBC muscle-invasive bladder cancer
NAC neoadjuvant chemotherapy
NUTRFS non-urinary tract recurrence-free survival
OS overall survival
PFS progression-free survival
RC radical cystectomy
RNU radical nephroureterectomy
UC urothelial carcinoma
UTUC upper tract urothelial carcinoma
ypT pathological T stage after neoadjuvant therapy
ypN pathological nodal status after neoadjuvant therapy